Sitemap
Update: July 26th, 2009
Sitemap of posts on Orshe.com
Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64
Posts
- Category: Wall Street Journal (continued)
- Don’t Buy Health Insurance? Your Tax Refund May Suffer.
- Don’t Hold Your Breath Waiting for a Female Sex Drug
- Don’t Let the Math Scare You, E.O. Wilson Tells Would-Be Science Students
- Don’t Like the Idea of Ground-Up Bugs? Better Read the Label
- Don’t Talk to Me About Financials, Says Novartis R&D Head
- Dorgan and McCain: Live in Concert! One Day Only!
- Dossia’s New CEO Michael Critelli Talks Lessons Learned
- Down to the Wire Again With Medicare Payment Cuts for Doctors
- Downbeat Public Losing Faith in Dems and GOP
- Downside of High-Deductible Plans
- Downside of Rural Medicine: Slow Internet, No iPhone, Dating Woes
- Dreams a Handy Plot Point in Hollywood
- Drinking Alcohol and Staying Healthy
- Drinking Fat: Viral Video as Public-Health Strategy
- Drowning in Health-Care Costs
- Drug Companies’ Overseas Operations Cause Tax Headaches
- Drug Firms Making Strides Against Prostate Cancer
- Drug Makers Circumvent Co-Pays Using Rebates
- Drug Makers Promise to Lower Prices
- Drug News: Impotence, Arthritis and Schizophrenia
- Drug Price Increases Come As Companies Peer Over Patent Cliff
- Drug Shortages Accompanied By Lack of Info, ‘Near Misses,’ Deaths
- Drug Spending Last Year Driven By Recession Recovery: Report
- Drug Spending Rose 3.6% Last Year, Express Scripts Report Says
- Drug-Maker Pens Are Endangered Species at Cancer Confab
- Drunken Driving On the Decline
- Dueling Estimates Over Popularity of a Public Health Plan
- E. coli Roundup: Source of Contamination Still Unknown
- Early Report Card on Healthy People 2010: (Barely) a C
- Early Winners and Losers in an Avalanche of ASCO Data
- Early-Onset Alzheimer's Disease: What Is It?
- Early-Retiree Health-Insurance Fund to Wind Down
- Earnings Call Is a Requiem for Schering-Plough
- Easing Chemo Treatments for Kids With Cancer
- Eat Less, Eat Better, Exercise More — And Here’s How
- ECO:nomics: Eating on $200 a Month?
- Educating Mothers About the Risks of Early Deliveries
- Egg Recall Roundup: Avoid Runny Yolks, FDA Head Says
- Eight-Way Kidney Transplant Sets Mark for Longest Chain
- Electrical Jolt Helps Paralyzed Man Stand and Move
- Electronic Medical Records Don’t Improve Outpatient Care Quality: Study
- Eli Lilly Adds Jobs, Plans Cuts
- Eli Lilly CEO Makes Case Against Public Health Insurance Plan
- Eli Lilly CEO’s 2009 Compensation Totaled $16.4 Million
- Eli Lilly Exec Heads to Harvard Med School
- Eli Lilly Isn’t Planning to Buy Its Way Around the Patent Cliff
- Eli Lilly’s Payments to Doctors Revealed
- Embryonic Stem Cells Without Embryos, Cont’d
- Emergency Contraceptive Pill Plan Blocked
- Employee-Benefit Costs Concern CFOs Most
- Employer Health Benefits Survey Shows Few Review Plan Quality
- Employer Health Insurance Mandates: House vs. Senate
- Employer Health Premiums Rise Sharply
- Employers Increased Wellness Incentives Last Year
- Employers Predict Their Health Costs Will Rise 5.9% Next Year
- Employers Say They Can't Afford Health Bill
- Employers Stand to Win Concession With Health Bill
- Employment Report Shows Health Care Added 31,300 Jobs
- English 101: Medicare is the Worst Literature
- Enzi A Quiet Force Amid Loud Health Reform Debate
- EPA Reviews Safety of Recycled Tires in Playgrounds
- Erbitux, Vectibix Label Change Approved for KRAS Gene
- Estimating the Economic Bite of the H1N1 Flu Pandemic
- Europe Gives Thumbs-Down to Erbitux for Treating Lung Cancer
- European Biotechs Rust On the Auction Block
- European Drug Makers: More Innovative Than U.S. Companies?
- European Pharma Industry Seen ‘Rising From the Ashes’ in Mid-2012
- European Regulators: Weigh Potential Narcolepsy Risk of Glaxo’s Pandemrix
- Even Women Most Everyone Agrees Should Get a Mammogram Don’t
- Even Young Kids Can Remember Events Years Later
- Ex-Medicare Chief Berwick Takes Gloves Off
- Ex-Wyeth CEO Bob Essner Moves to Private Equity’s Carlyle Group
- Examining the Science of Medical Marijuana
- Exchanging Art for Health Care
- Expanding Diabetes Screening
